Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules

Clinical trial NCT00661713 · COMPLETED

Trial details

NCT number: NCT00661713
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Meningococcal Disease

Start date: 2008-06-01
Primary completion: 2010-04-01
Enrollment: 1631

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.